CN115219614B - High performance liquid chromatography detection method for chlorbenzoguanide hydrochloride in chicken excreta - Google Patents
High performance liquid chromatography detection method for chlorbenzoguanide hydrochloride in chicken excreta Download PDFInfo
- Publication number
- CN115219614B CN115219614B CN202210707104.0A CN202210707104A CN115219614B CN 115219614 B CN115219614 B CN 115219614B CN 202210707104 A CN202210707104 A CN 202210707104A CN 115219614 B CN115219614 B CN 115219614B
- Authority
- CN
- China
- Prior art keywords
- hydrochloride
- phase
- chicken
- high performance
- liquid chromatography
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 67
- 241000287828 Gallus gallus Species 0.000 title claims abstract description 61
- 210000003608 fece Anatomy 0.000 title claims abstract description 56
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims abstract description 51
- 238000004128 high performance liquid chromatography Methods 0.000 title claims abstract description 27
- 238000000034 method Methods 0.000 claims abstract description 26
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 60
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 24
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 18
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 15
- 235000019253 formic acid Nutrition 0.000 claims description 15
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 238000004108 freeze drying Methods 0.000 claims description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 10
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 9
- 238000010828 elution Methods 0.000 claims description 8
- 239000007864 aqueous solution Substances 0.000 claims description 6
- 238000000265 homogenisation Methods 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 6
- 239000007924 injection Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 4
- 239000005499 Clomazone Substances 0.000 claims description 2
- KIEDNEWSYUYDSN-UHFFFAOYSA-N clomazone Chemical compound O=C1C(C)(C)CON1CC1=CC=CC=C1Cl KIEDNEWSYUYDSN-UHFFFAOYSA-N 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 13
- 239000012535 impurity Substances 0.000 abstract description 11
- 238000011084 recovery Methods 0.000 abstract description 11
- 239000003814 drug Substances 0.000 abstract description 9
- 229940079593 drug Drugs 0.000 abstract description 9
- 230000029142 excretion Effects 0.000 abstract description 9
- 238000000926 separation method Methods 0.000 abstract description 8
- KBLCYCIJBGJKMW-UHFFFAOYSA-N 1-chloro-1-phenylguanidine;hydrochloride Chemical compound Cl.NC(=N)N(Cl)C1=CC=CC=C1 KBLCYCIJBGJKMW-UHFFFAOYSA-N 0.000 abstract description 7
- 230000035945 sensitivity Effects 0.000 abstract description 6
- 230000008569 process Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000005259 measurement Methods 0.000 abstract description 3
- 238000004451 qualitative analysis Methods 0.000 abstract description 3
- 238000004445 quantitative analysis Methods 0.000 abstract description 3
- 239000002689 soil Substances 0.000 abstract description 3
- 208000003495 Coccidiosis Diseases 0.000 abstract description 2
- 206010023076 Isosporiasis Diseases 0.000 abstract description 2
- 238000012544 monitoring process Methods 0.000 abstract description 2
- 230000002265 prevention Effects 0.000 abstract description 2
- 238000011160 research Methods 0.000 abstract description 2
- NOXNCSQBTYNMHD-UHFFFAOYSA-N 3-(4-chlorophenyl)-n,n-dimethyl-3-pyridin-2-ylpropan-1-amine;hydron;chloride Chemical compound Cl.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 NOXNCSQBTYNMHD-UHFFFAOYSA-N 0.000 abstract 4
- 235000013330 chicken meat Nutrition 0.000 description 52
- 239000012071 phase Substances 0.000 description 34
- 239000003153 chemical reaction reagent Substances 0.000 description 12
- 239000010871 livestock manure Substances 0.000 description 10
- 238000000605 extraction Methods 0.000 description 9
- 238000005070 sampling Methods 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 6
- 238000005457 optimization Methods 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 238000002203 pretreatment Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000007710 freezing Methods 0.000 description 5
- 230000008014 freezing Effects 0.000 description 5
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 description 5
- 238000011002 quantification Methods 0.000 description 5
- 230000004044 response Effects 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000005303 weighing Methods 0.000 description 4
- 239000012224 working solution Substances 0.000 description 4
- XBJFCYDKBDVADW-UHFFFAOYSA-N acetonitrile;formic acid Chemical compound CC#N.OC=O XBJFCYDKBDVADW-UHFFFAOYSA-N 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 238000007664 blowing Methods 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 230000002550 fecal effect Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 238000012417 linear regression Methods 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 238000001291 vacuum drying Methods 0.000 description 2
- 241000224483 Coccidia Species 0.000 description 1
- 241000223924 Eimeria Species 0.000 description 1
- 241000223931 Eimeria acervulina Species 0.000 description 1
- 241000499566 Eimeria brunetti Species 0.000 description 1
- 241000499563 Eimeria necatrix Species 0.000 description 1
- 241000223932 Eimeria tenella Species 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000006053 animal diet Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000001165 anti-coccidial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 238000000861 blow drying Methods 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- WRWJHZAQLXGJQX-UHFFFAOYSA-N ethyl acetate;formic acid Chemical compound OC=O.CCOC(C)=O WRWJHZAQLXGJQX-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- HQVFCQRVQFYGRJ-UHFFFAOYSA-N formic acid;hydrate Chemical compound O.OC=O HQVFCQRVQFYGRJ-UHFFFAOYSA-N 0.000 description 1
- 229960000789 guanidine hydrochloride Drugs 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- PJJJBBJSCAKJQF-UHFFFAOYSA-N guanidinium chloride Chemical compound [Cl-].NC(N)=[NH2+] PJJJBBJSCAKJQF-UHFFFAOYSA-N 0.000 description 1
- 229940083094 guanine derivative acting on arteriolar smooth muscle Drugs 0.000 description 1
- 238000000589 high-performance liquid chromatography-mass spectrometry Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000002414 normal-phase solid-phase extraction Methods 0.000 description 1
- 244000144977 poultry Species 0.000 description 1
- 235000013594 poultry meat Nutrition 0.000 description 1
- 238000007781 pre-processing Methods 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000009489 vacuum treatment Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/42—Low-temperature sample treatment, e.g. cryofixation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/12—Preparation by evaporation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/14—Preparation by elimination of some components
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/30—Control of physical parameters of the fluid carrier of temperature
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/32—Control of physical parameters of the fluid carrier of pressure or speed
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/62—Detectors specially adapted therefor
- G01N30/74—Optical detectors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/86—Signal analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N2030/062—Preparation extracting sample from raw material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/12—Preparation by evaporation
- G01N2030/121—Preparation by evaporation cooling; cold traps
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
- G01N30/14—Preparation by elimination of some components
- G01N2030/146—Preparation by elimination of some components using membranes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/30—Control of physical parameters of the fluid carrier of temperature
- G01N2030/3007—Control of physical parameters of the fluid carrier of temperature same temperature for whole column
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/32—Control of physical parameters of the fluid carrier of pressure or speed
- G01N2030/324—Control of physical parameters of the fluid carrier of pressure or speed speed, flow rate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/26—Conditioning of the fluid carrier; Flow patterns
- G01N30/28—Control of physical parameters of the fluid carrier
- G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
- G01N2030/342—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient fluid composition fixed during analysis
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The application discloses a high performance liquid chromatography detection method of chlorbenzoguanamine hydrochloride in chicken excreta. The high performance liquid chromatography detection method of the chlorphenyl guanidine hydrochloride in chicken excreta comprises two steps of pretreatment and high performance liquid chromatography detection, the impurity peak and the main peak of the chlorphenyl guanidine hydrochloride of the sample treated by the pretreatment process have good separation effect, the main peak has good peak type, the detection limit and the quantitative limit of the detection method can meet the requirements of qualitative and quantitative analysis of medicines, and the detection sensitivity, the reproducibility, the accuracy, the recovery rate and the like can also meet the detection requirements. The method disclosed by the application not only can meet the content measurement of the chlorpheniramine hydrochloride in chicken excreta and the excretion research in chicken bodies, but also is beneficial to monitoring the influence of the chlorpheniramine hydrochloride on water sources, soil and the like after the chlorpheniramine hydrochloride is discharged into the environment along with the chicken excreta, and the reasonable application of the chlorpheniramine hydrochloride in the field of chicken coccidiosis prevention and treatment is monitored.
Description
Technical Field
The application belongs to the technical field of drug detection. More particularly relates to a high performance liquid chromatography detection method of the chlorbenzoguanamine hydrochloride in chicken excreta.
Background
The chlorbenzoguanamine hydrochloride belongs to guanidine derivatives, is an artificially synthesized anticoccidial drug, is mainly used for preventing and treating acute and chronic coccidian infection of chickens, and has good effects on Eimeria tenella, eimeria necatrix, eimeria acervulina, eimeria brunetti, eimeria mutans and the like. However, the excessive use or improper use of the chlorbenzoguanide hydrochloride, such as the illegal addition of high doses of chlorbenzoguanide hydrochloride in the feed, causes residues in the animal body and endangers the health of the human body; part of the animal excreta can be discharged in the form of original shape or metabolites along with the animal excreta, and the animal excreta can be scattered in farmlands as fertilizer, so that soil, water body and the like are polluted, the microbial ecological chain of the environment is influenced, and great risks exist for the environment and human health. Therefore, there is a need to establish a method for detecting the content of the chlorbenzoguanamine hydrochloride in the chicken excreta with high detection sensitivity and accurate detection result, and the method can be used for detecting the content of the chlorbenzoguanamine hydrochloride in the chicken excreta, so as to further judge whether the behavior of illegally adding the high-dose chlorbenzoguanamine hydrochloride into the feed exists.
At present, the separation and detection methods reported at home and abroad mainly comprise thin layer chromatography, high performance liquid chromatography and liquid chromatography-tandem mass spectrometry (LC-MS/MS). Although the thin layer chromatography has the advantages of simple and convenient operation, the qualitative and quantitative effects are poor, and the sensitivity is not high; although the liquid chromatography-tandem mass spectrometry has accurate qualitative and quantitative results and short peak time, the existing liquid quality detection method for the content of the chlorobenzoguanidine hydrochloride needs to use the chlorobenzoguanidine-D8 as an internal standard, and the pretreatment process needs to be subjected to column passing purification twice, so that the operation flow is complex and the time consumption is long. In addition, the existing separation and detection method of the chlorbenzoguanamine hydrochloride mainly aims at animal tissues such as muscles, livers, kidneys and the like, and at least the existing separation and detection method of the chlorbenzoguanamine hydrochloride in animal excreta is very few. Hu Shuangqing discloses a method for simultaneously detecting six types of 24 antibiotics in livestock and poultry manure by combining ultrasonic extraction-solid phase extraction pretreatment with liquid chromatography-tandem mass spectrometry, but the method utilizes liquid chromatography-tandem mass spectrometry and has the defects of complex pretreatment process operation, more reagents, long time consumption and the like.
Disclosure of Invention
The application aims to overcome the defects and the shortcomings of the prior art and provide a high performance liquid chromatography detection method for the chlorbenzoguanide hydrochloride in chicken excreta.
The above object of the present application is achieved by the following technical scheme:
the application provides a high performance liquid chromatography detection method of chlorbenzoguanamine hydrochloride in chicken excreta, which comprises the following steps:
s1, pretreatment: lyophilizing chicken excrement, adding pretreatment liquid, homogenizing, centrifuging to obtain supernatant, concentrating, redissolving, and filtering;
s2, high performance liquid chromatography detection.
The application can solve the problem of impurity interference caused by large sample sampling amount by freeze drying treatment of chicken excreta; secondly, the problems that the samples are difficult to homogenize and the samples are not uniform due to the fact that the water content of the chicken excrement is high can be solved.
Specifically, the preprocessing step in step S1 is as follows: freeze drying chicken excrement, adding acidified pretreatment liquid for homogenizing, centrifuging to obtain supernatant, concentrating, re-dissolving the residue with methanol, adding equal volume of n-hexane, mixing, centrifuging, and removing the lower layer liquid filtering membrane.
Specifically, the chicken excreta comprises urine and feces.
Specifically, the freeze-drying treatment is: quick freezing the sample in a refrigerator at-80 deg.c, and vacuum drying after freezing.
Specifically, the centrifugal temperature in the step S1 is 4 ℃, and the rotating speed is 5000-8000 r.min -1 The time is 5-10 min.
In order to remove impurities as much as possible, the application carries out two times of centrifugation, namely, the homogenization treatment is carried out at 4 ℃ and 8000 r.min -1 Centrifuging for 10min, sucking the upper layer extractive solution again at 4deg.C and 8000 r.min -1 And centrifuged again for 10min.
Preferably, the centrifugal rotational speed is 8000 r.min -1 The time was 10min, see example 1.
Specifically, the acidified pretreatment liquid is ethyl acetate containing formic acid or acetonitrile containing formic acid, and the volume percentage of the formic acid is 1-2%.
Preferably, the pretreatment liquid is acetonitrile containing 2% (v/v) formic acid, see example 1.
Specifically, the filter membrane is a 0.22 μm filter membrane.
Specifically, the chromatographic conditions of the high performance liquid chromatography detection in step S2 are as follows: chromatographic column: a C18 chromatographic column; mobile phase: the phase A (aqueous phase) is 0.1-0.2% formic acid aqueous solution or 0.025-0.01 moL/L phosphoric acid aqueous solution, and the phase B (organic phase) is methanol or acetonitrile according to the volume ratio A: b= (55 to 65): (35-45), gradient elution with the flow rate of 0.8-1.2 mL/min; sample injection volume: 15-25 mu L; column temperature: 38-42 ℃; detection wavelength: 300-330 nm.
Specifically, the column was a Agilent ZORBAX SB-C18 column (4.6mm.times.250mm, 5 μm), i.e., the inner diameter of the column was 4.6mm, the column length was 250mm, and the particle size of the packing was 5 μm.
Preferably, the A phase is 0.025moL/L aqueous phosphoric acid and the B phase is acetonitrile, see example 2.
Specifically, the gradient elution procedure is: 0-4 min,35% of phase B; 4-4.10 min,45% of phase B; 4.10-15 min,45% of phase B; 15-15.10 min,35% of phase B; 15.10-18 min,35% of phase B.
In particular, the detector used is a diode array detector; the flow rate is 1mL/min; the sample injection volume is 20 mu L; column temperature is 40 ℃; the PDA detection wavelength is 312nm.
After the key steps are optimized, the method for detecting the high performance liquid chromatography of the chlorbenzoguanamine hydrochloride in the chicken excrement comprises the following specific steps:
s1, pretreatment: lyophilizing chicken excreta, adding acetonitrile containing 2% (v/v) formic acid, homogenizing, i.e. extracting with strong shaking vortex for 2-5 min at 4deg.C and 8000r min -1 Centrifuging for 10min, sucking the upper layer extractive solution into a new centrifuge tube, and centrifuging at 4deg.C at 8000 r.min -1 Centrifuging for 10min again, sucking the upper layer extractive solution into another new centrifuge tube, and blowing up at 45deg.C with nitrogen blowerNear-drying; redissolving the residue with methanol, swirling for 30s, adding equal volume of n-hexane, swirling again for 30s at 4deg.C at 8000 r.min -1 Centrifuging for 10min; discarding the upper viscous liquid, transferring the lower solution into a centrifuge tube, and transferring at 4deg.C for 15000 r.min -1 And centrifuging again for 10min, and filtering the lower clarified liquid through a 0.22 mu m filter membrane to obtain a sample to be tested.
S2, high performance liquid chromatography detection, and a detector: a diode array detector; the chromatographic conditions are as follows: chromatographic column: agilent ZORBAX SB-C18 (4.6 mm. Times.250 mm,5 μm); mobile phase: phase A was 0.025moL/L phosphoric acid in water and phase B was acetonitrile, gradient elution procedure: 0-4 min,35% of phase B; 4-4.10 min,45% of phase B; 4.10-15 min,45% of phase B; 15-15.10 min,35% of phase B; 15.10-18 min,35% of phase B; flow rate: 1mL/min; sample injection volume: 20. Mu.L; column temperature: 40 ℃; PDA detection wavelength: 312nm.
The application has the following beneficial effects:
the application provides a high performance liquid chromatography detection method of chlorphenyl guanidine hydrochloride in chicken excreta, which comprises two steps of pretreatment of excreta samples and high performance liquid chromatography detection, wherein the separation effect of an interference peak and a main peak of the chlorphenyl guanidine hydrochloride of the samples treated by the pretreatment process is good, the main peak type is good, the detection limit and the quantitative limit of the detection method can meet the requirements of qualitative and quantitative analysis of medicines, and the detection sensitivity, the reproducibility, the accuracy, the recovery rate and the like can also meet the detection requirements.
The detection method disclosed by the application not only can meet the content measurement of the chlorphenidine hydrochloride in chicken excreta and the excretion research in chicken bodies, but also is beneficial to monitoring the influence of the chlorphenidine hydrochloride on water sources, soil and the like after the chlorphenidine hydrochloride is discharged into the environment along with the chicken excreta, and the reasonable application of the chlorphenidine hydrochloride in the field of chicken coccidiosis prevention and treatment.
Drawings
FIG. 1 is a standard graph obtained by examining the linear relationship in example 3 of the present application.
FIG. 2 is a chromatogram corresponding to the detection limit in example 3 of the present application.
FIG. 3 is a chromatogram corresponding to the limit of quantification described in example 3 of the present application.
FIG. 4 is a chromatogram of a blank fecal sample according to example 4 of the present application.
FIG. 5 is a chromatogram of a standard working solution (1. Mu.g/mL) of the blank stool added with progenitrile hydrochloride according to example 4 of the present application.
FIG. 6 is a chromatogram of an actual chicken excreta sample as described in example 4.
Detailed Description
The application is further illustrated in the following drawings and specific examples, which are not intended to limit the application in any way. Unless specifically stated otherwise, the reagents, methods and apparatus employed in the present application are those conventional in the art.
Reagents and materials used in the following examples are commercially available unless otherwise specified.
Example 1 optimization of sample pretreatment conditions
1. Effect of chicken excreta freeze drying on homogenization treatment
The water content of the fresh chicken excreta (comprising urine and feces) is 50-60%, and the fresh chicken excreta is influenced by the water content of the fresh chicken excreta, if the sampling amount is small in the pretreatment process, the problem of uneven sampling can occur, and the water content cannot represent the change of the drug concentration in an actual sample; and excessive sampling amount is easy to cause excessive response of impurities in the matrix and influence the problem of low concentration quantification. Therefore, the chicken excreta is subjected to freeze-drying treatment, and the influence on homogenization treatment after the chicken excreta freeze-drying treatment is explored; the freeze drying treatment comprises the following steps: quick freezing the sample in a refrigerator at-80 deg.c, and vacuum drying after freezing.
Taking an equal amount of fresh chicken excreta, freeze-drying to semi-dry and completely dry chicken excreta, adding the same solvent, strongly shaking, vortex-extracting for 5min, and observing the homogenizing effect, wherein the result is shown in Table 1:
TABLE 1 Effect of different moisture content of chicken excreta on homogenization treatment effect
2. Centrifugal condition optimization
Although the method of freeze drying chicken excreta and then homogenizing is adopted, the problems of excessive impurity response caused by excessive sampling amount, influence on quantification and uneven sampling can be avoided. However, after adding the extraction reagent for homogenization, the extraction reagent system becomes very turbid, which is unfavorable for subsequent detection. In order to obtain a clear extraction reagent system, the application performs an influence test of the centrifugal speed and the centrifugal time on the extraction effect, and the results are shown in table 2. As is clear from the results shown in Table 2, when the rotational speed is 8000 rmin -1 When the centrifugation time is 10min, the system state is clear and transparent, so that impurities in chicken manure samples can be well removed, and interference is reduced.
TABLE 2 influence of centrifuge time and speed on System State
3. Optimization of drug extraction reagents
The results of the preliminary test show that the application has better effect by using ethyl acetate or acetonitrile as an extraction reagent, and in order to further optimize the application, after the chicken excreta are freeze-dried, the application extracts and recovers the chlorbenzoguanamine hydrochloride in the chicken excreta by respectively using 1% (v/v) formic acid to acidify the ethyl acetate, 1% (v/v) formic acid to acidify the acetonitrile, 0.1% (v/v) formic acid to acidify the acetonitrile and 2% (v/v) formic acid to acidify the acetonitrile.
Adding lyophilized chicken excreta into 1% (v/v) formic acid ethyl acetate, 1% (v/v) formic acid acetonitrile, 0.1% (v/v) formic acid acetonitrile and 2% (v/v) formic acid acetonitrile, and extracting with strong shaking vortex for 3min at 4deg.C and 8000 r.min -1 Centrifuging for 10min, sucking the upper layer extract into a new centrifuge tube, and blowing up to near dryness with a nitrogen blower at 45deg.C; redissolving the residue with methanol, swirling for 30s, adding equal volume of n-hexane, swirling again for 30s at 4deg.C at 8000 r.min -1 Centrifuging for 10min; the upper viscous liquid was discarded, the lower clarified liquid was filtered through a 0.22 μm filter to obtain the sample to be tested, and the recovery test results are shown in Table 3. As is clear from the results shown in Table 3, when 2% (v/v) formic acid-acidified acetonitrile was used as the extraction reagent, the recovery rate of the chlorobenzoguanidine hydrochloride was high, and the parallelism was good, so that 2% (v/v) formic acid-acidified acetonitrile was subsequently selected as the extraction reagent.
TABLE 3 influence of different extraction reagents on recovery
4. Determination of pretreatment method
After a series of optimization, the pretreatment method of the chicken excrement is determined as follows: weighing 0.20 g+ -0.01 g of freeze-dried chicken manure in a 50mL centrifuge tube, adding 10mL acetonitrile containing 2% (v/v) formic acid, extracting with strong shaking vortex for 2min, extracting at 4deg.C for 8000 r.min -1 Centrifuging for 10min, collecting supernatant, and centrifuging at 4deg.C and 8000 r.min -1 Centrifuging again for 10min, collecting supernatant, and blow-drying on nitrogen blower at 45deg.C; the residue was redissolved in 1mL of methanol, vortexed for 30s, then added with 1mL of n-hexane, vortexed again for 30s, and at 4℃8000 r.min -1 Centrifuging for 10min; discarding the upper viscous liquid, transferring the lower solution into a 2mL centrifuge tube, and transferring the lower solution into 15000 r.min at 4deg.C -1 Centrifuging again for 10min, taking the clarified liquid at the lower layer, and filtering with a 0.22 μm filter membrane to obtain a sample to be tested, and performing HPLC analysis.
EXAMPLE 2 optimization of chromatographic conditions
1. Determination of detection wavelength
When the high performance liquid chromatography detection is carried out on the obtained sample to be detected, the detector is a diode array, chromatographic conditions of the high performance liquid chromatography detection are further optimized to improve detection sensitivity, accuracy and the like, the detector carries out full-wavelength detection on the chlorphenyl guanidine hydrochloride standard solution (1 mug/mL) through the diode array detector of the high performance liquid chromatograph, the response value and the peak area of the chlorphenyl guanidine hydrochloride in the wavelength range of 200-400 nm are compared, and the result shows that the chlorphenyl guanidine hydrochloride has higher response intensity in the wavelength range of 300-330 nm, has the highest response intensity at 312nm and can meet the detection requirement. Therefore, 312nm is selected as the final detection wavelength in the method.
2. Selection of mobile phases in chromatographic conditions
The application optimizes the chromatographic conditions by adopting different organic phases and water phases respectively. According to the application, methanol and acetonitrile are respectively used as organic phases, high performance liquid chromatography detection is carried out on a standard solution (1 mug/mL) of the chlorbenzoguanamine hydrochloride, and as a result, the acetonitrile has stronger eluting capability on the chlorbenzoguanamine hydrochloride, better peak type and smaller viscosity, and under the premise of the same other chromatographic conditions, the column efficiency is higher and the column pressure is lower, so that the acetonitrile is selected as the organic phase for HPLC analysis.
According to the application, 0.1% formic acid water and 0.025moL/L phosphoric acid water are respectively used as water phases, high performance liquid chromatography detection is carried out on a standard solution of the chlorobenzoguanidine hydrochloride (1 mu g/mL), and as a result, when 0.025moL/L phosphoric acid water is used as a water phase mobile phase, the obtained chromatographic peak of the chlorobenzoguanidine hydrochloride is sharper and more symmetrical, the tailing factor (T) is between 0.95 and 1.05, the separation degree is more than 1.5, the theoretical plate number is more than 2000, and therefore, 0.025moL/L phosphoric acid water is selected as the water phase for HPLC analysis.
After determining the reagents used for the mobile phase, the present application detects the presence of the guanidine hydrochloride in chicken excreta using different phase ratios of the same flow, i.e., 20%, 25%, 30%, 35%, 40%, 45%, 50% and 55% (v/v). As a result, it was found that the effect of the off-peak of the clomazone hydrochloride was good in the 45% organic phase state, the peak was sharp and symmetrical, and the effect of separating the impurity peaks in the matrix was good. In combination with consideration of peak time and separation degree of main peak and impurity peak, the application finally determines to use an organic phase gradient elution mode from 35% to 45%. The gradient procedure is detailed in table 4 below:
TABLE 4 gradient elution procedure
3. Determination of chromatographic conditions
After a series of optimization, the application determines chromatographic conditions of the high performance liquid chromatography detection, and the chromatographic conditions are specifically as follows: a detector: a diode array detector; detection wavelength: 312nm; chromatographic column: agilent ZORBAX SB-C18 (4.6 mm. Times.500 mm,5 μm); mobile phase: phase A was 0.025moL/L phosphoric acid in water and phase B was acetonitrile, gradient elution procedure: 0-4 min,35% of phase B; 4-4.10 min,45% of phase B; 4.10-15 min,45% of phase B; 15-15.10 min,35% of phase B; 15.10-18 min,35% of phase B; flow rate: 1mL/min; sample injection volume: 20. Mu.L; column temperature: 40 ℃; PDA detection wavelength: 312nm.
EXAMPLE 3 methodology investigation
1. Linear relationship investigation
A plurality of parts of 0.20g of freeze-dried chicken manure are accurately weighed, 100 mu L of standard working solution of the chlorobenzoguanidine hydrochloride is sequentially added, so that the mass concentration of the added chlorobenzoguanidine hydrochloride is 0.02mg/kg, 0.5mg/kg, 2mg/kg, 5mg/kg, 10 mg/kg, 20 mg/kg, 40mg/kg and 50mg/kg respectively, the added chlorobenzoguanidine hydrochloride is processed according to the pretreatment method determined in the embodiment 1 of the application, the measurement is carried out according to the chromatographic conditions determined in the embodiment 2, and the HPLC analysis is carried out by sequentially sampling according to the sequence from low concentration to high concentration.
Drawing a standard curve by taking the measured chromatographic peak area (A) of the chlorbenzoguanamine hydrochloride as an abscissa and the drug concentration (C) as an ordinate to obtain a linear regression equation and a correlation coefficient; as shown in fig. 1, the standard curve shows a good linear relationship in the detection method as shown in fig. 1. The linear regression equation was c= 8.6441 ×10 -5 A+0.1174, linear correlation coefficient R 2 =0.9997。
2. Detection and quantification limit
0.20g of blank lyophilized chicken manure is accurately weighed, and standard solutions of chlorobenzoguanidine hydrochloride with mass concentrations of 0.01mg/kg, 0.02mg/kg, 0.05mg/kg, 0.1mg/kg, 0.2mg/kg and 0.5mg/kg are respectively added, treated according to the pretreatment method described in example 1, and measured according to the chromatographic conditions described in example 2, wherein the detection Limit (LOD) is calculated with S/N not less than 3, and the quantitative Limit (LOQ) is calculated with S/N not less than 10.
The detection limit of the detection method for the chlorbenzoguanamine hydrochloride in the chicken excreta is 0.01mg/kg, and a chromatogram corresponding to the detection limit is shown in figure 2; the quantitative limit of the detection method on the chlorbenzoguanamine hydrochloride in the chicken excreta is 0.02mg/kg, and a chromatogram corresponding to the quantitative limit is shown in figure 3.
3. Recovery rate and precision
Accurately weighing 0.20g of blank freeze-dried chicken manure, adding a standard working solution of the chlorbenzoguanamine hydrochloride, so that the mass concentration of the chlorbenzoguanamine hydrochloride after the addition is respectively 0.5, 5 and 40mg/kg, wherein 5 mass concentrations are parallel, processing according to the pretreatment method described in the embodiment 1, measuring according to the chromatographic conditions described in the embodiment 2, comparing the peak area of the measured chlorbenzoguanamine hydrochloride with the peak area of a standard product with the corresponding concentration, quantifying by a single-point method, calculating the absolute recovery rate of the chlorbenzoguanamine hydrochloride in a manure sample, and performing accuracy analysis; and 3 analytical batches were prepared and examined consecutively on different days, and the method was evaluated for intra-and inter-batch precision with relative standard deviation, and the results are shown in Table 5:
TABLE 5 absolute recovery of Chlorobenzguanide hydrochloride and relative Standard deviation between batches
As can be seen from the results shown in Table 5, the average recovery rate of the chlorobenzoguanidine hydrochloride in the chicken manure sample at 3 addition concentrations (0.5, 5, 40 mg/kg) was 91.26% -103.46%, the relative standard deviation between batches was 1.44% -4.49%, the relative standard deviation between batches was 4.12% -5.97%, and the recovery rate and precision were both at high levels.
The result shows that the detection limit and the quantitative limit of the high performance liquid chromatography detection method of the chlorbenzoguanamine hydrochloride in the chicken excrement meet the requirements of qualitative and quantitative analysis of medicines, and the detection sensitivity is high, and the method has the advantages of high recovery rate, high precision, good repeatability and high accuracy.
Example 4 actual sample detection
1. Experimental animal and sample collection
10 healthy Yue-bird king hens with the age of 30 weeks are placed in a metabolism cage for independent feeding, the average weight is 1.42+/-0.14 kg, animal diet, behavior, physical characteristics and the like are observed before test development, and subsequent experiments are carried out after clinical manifestations are healthy; suspending the chlorbenzoguanamine hydrochloride in 0.1% sodium carboxymethylcellulose aqueous solution to prepare an oral liquid with the concentration of 5mg/mL, preparing the oral liquid by pouring in a 15 mg/kg.bw dosage currently, respectively 4h, 8h, 12h, 24h, 36h, 48h, 60h, 72h, 84h, 96h, 108h, 120h, 132h, 144h, 156h and 168h before and after the administration, collecting all fecal-urine mixtures, weighing and recording wet weights; quickly freezing the sample in a refrigerator at-80 ℃, carrying out vacuum treatment after the sample is completely frozen, weighing again after the sample is completely freeze-dried (the water content is less than 2%), and recording the dry weight of the sample; the resulting chicken excreta samples were sealed and stored in a foam box with desiccant for testing.
2. Sample detection and results
The resulting chicken excreta samples were each treated according to the pretreatment method described in example 1 and were assayed according to the chromatographic conditions described in example 2; in addition, after addition of a standard solution of chlorobenzoguanidine hydrochloride (1. Mu.g/mL) to the blank chicken manure, the resulting chicken manure samples were treated separately in the same manner as in the pretreatment described in example 1 and were assayed according to the chromatographic conditions described in example 2.
The chromatogram of the blank fecal sample is shown in fig. 4; the chromatogram of the standard working solution (1 mug/mL) with the addition of the chlorbenzoguanamine hydrochloride to the blank feces is shown in FIG. 5; the chromatogram of the actual chicken faeces sample is shown in figure 6. The result shown in fig. 5 shows that the retention time of the chlorbenzoguanamine hydrochloride is 11.567min, which is consistent with the retention time in the chromatogram (fig. 6) of the actual chicken excrement sample, and meanwhile, the blank excrement sample has no impurity peak at the corresponding time point (fig. 4), which shows that no other impurity is interfered near the retention time of the chlorbenzoguanamine hydrochloride, and the endogenous impurities of the sample can not influence the detection of the drug chlorbenzoguanamine hydrochloride by the detection method provided by the application, so that the separation effect is good, the quantification is accurate, and the detection requirement can be met. In addition, according to the detection result of an actual sample, after the chicken takes the chlorbenzoguanamine hydrochloride orally, the chlorbenzoguanamine hydrochloride can be discharged out of the body along with excrement quickly, the period of 0-4 hours is a excretion peak period, the average excretion amount is 6514.88 +/-1714.44 mug, and the chicken accounts for 75.56 percent of the accumulated excretion amount and accounts for 29.84 percent of the administration dosage; the main excretion time is within 24 hours after administration, and the excretion amount accounts for 93.50% of the accumulated excretion amount; the drug administration is carried out for 7 days, and the excretion is basically completed.
The above examples are preferred embodiments of the present application, but the embodiments of the present application are not limited to the above examples, and any other changes, modifications, substitutions, combinations, and simplifications that do not depart from the spirit and principle of the present application should be made in the equivalent manner, and the embodiments are included in the protection scope of the present application.
Claims (4)
1. The high performance liquid chromatography detection method of the clomazone hydrochloride in chicken excreta is characterized by comprising the following steps of:
s1, pretreatment: freeze drying chicken excrement, adding acidified pretreatment liquid for homogenization treatment, centrifuging to obtain supernatant, concentrating, re-dissolving the obtained residue with methanol, adding equal volume of n-hexane, mixing, centrifuging, and collecting lower layer liquid filtering membrane; the acidified pretreatment liquid is ethyl acetate containing formic acid or acetonitrile containing formic acid, and the volume percentage of the formic acid is 1% -2%; the centrifugal temperature is 4 ℃, and the rotating speed is 5000-8000 r.min -1 The time is 5-10 min;
s2, high performance liquid chromatography detection; the chromatographic conditions of the high performance liquid chromatography detection are as follows: chromatographic column: a C18 chromatographic column; mobile phase: the phase A is 0.1 to 0.2 percent formic acid aqueous solution or 0.025 to 0.01moL/L phosphoric acid aqueous solution, and the phase B is methanol or acetonitrile; the gradient elution procedure was: 0-4 min,35% of phase B; 4-4.10 min,45% of phase B; 4.10-15 min,45% of phase B; 15-15.10 min,35% of phase B; 15.10-18 min,35% of phase B, and gradient elution at the flow rate of 0.8-1.2 mL/min; sample injection volume: 15-25 mu L; column temperature: 38-42 ℃; detection wavelength: 300-330 and nm.
2. The method according to claim 1, wherein the chromatographic column is a Agilent ZORBAX SB-C18 chromatographic column, the inner diameter of the column is 4.6mm, the column length is 250mm, and the particle size of the packing is 5 μm.
3. The method according to claim 1, wherein the phase A is 0.025moL/L phosphoric acid aqueous solution and the phase B is acetonitrile.
4. The method of claim 1, wherein the detector used is a diode array detector; the flow rate is 1mL/min; the sample injection volume is 20 mu L; column temperature is 40 ℃; the PDA detection wavelength was 312nm.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210707104.0A CN115219614B (en) | 2022-06-21 | 2022-06-21 | High performance liquid chromatography detection method for chlorbenzoguanide hydrochloride in chicken excreta |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210707104.0A CN115219614B (en) | 2022-06-21 | 2022-06-21 | High performance liquid chromatography detection method for chlorbenzoguanide hydrochloride in chicken excreta |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115219614A CN115219614A (en) | 2022-10-21 |
CN115219614B true CN115219614B (en) | 2023-10-24 |
Family
ID=83608531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210707104.0A Active CN115219614B (en) | 2022-06-21 | 2022-06-21 | High performance liquid chromatography detection method for chlorbenzoguanide hydrochloride in chicken excreta |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115219614B (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107907620A (en) * | 2017-11-22 | 2018-04-13 | 上海市环境科学研究院 | The method that ultrasonic extraction Solid Phase Extraction pre-treatment combination LC-MS technology detects six 24 kinds of antibiotic of class in feces of livestock and poultry at the same time |
CN109709227A (en) * | 2018-12-30 | 2019-05-03 | 中国水产科学研究院长江水产研究所 | High performance liquid chromatography-tandem mass measures the method for robenidine hydrochloride and its metabolite residue amount in aquatic products |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE50002340D1 (en) * | 1999-01-06 | 2003-07-03 | Lonza Ag | METHOD FOR PRODUCING ROBENIDINE OR WHOSE DERIVATIVES |
-
2022
- 2022-06-21 CN CN202210707104.0A patent/CN115219614B/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107907620A (en) * | 2017-11-22 | 2018-04-13 | 上海市环境科学研究院 | The method that ultrasonic extraction Solid Phase Extraction pre-treatment combination LC-MS technology detects six 24 kinds of antibiotic of class in feces of livestock and poultry at the same time |
CN109709227A (en) * | 2018-12-30 | 2019-05-03 | 中国水产科学研究院长江水产研究所 | High performance liquid chromatography-tandem mass measures the method for robenidine hydrochloride and its metabolite residue amount in aquatic products |
Non-Patent Citations (3)
Title |
---|
Determination of robenidine residues in chicken muscle by high performance liquid chromatography with ultraviolet detection;Hyesun Yeom 等;Arch. Pharm. Res.;第36卷;395-365 * |
盐酸氯苯胍灌服后在兔尿液和粪便中的排泄规律;田苗苗 等;华南农业大学学报;第36卷(第03期);8-10 * |
高效液相色谱法测定鸡组织与鸡蛋中氯苯胍的残留量;刘勇军 等;色谱;第28卷(第09期);905-907 * |
Also Published As
Publication number | Publication date |
---|---|
CN115219614A (en) | 2022-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Xiong et al. | Simple and sensitive monitoring of β2-agonist residues in meat by liquid chromatography–tandem mass spectrometry using a QuEChERS with preconcentration as the sample treatment | |
CN103869041A (en) | Quality control method for cough-relieving oral pharmaceutical composition | |
CN116148387A (en) | Catecholamine and catecholamine metabolite detection method and kit | |
Hanai et al. | Simple liquid-chromatographic measurement of vanillylmandelic acid and homovanillic acid in urine on filter paper for mass screening of neuroblastoma in infants. | |
Zhang et al. | Evaluation of the oxidative deoxyribonucleic acid damage biomarker 8-hydroxy-2′-deoxyguanosine in the urine of leukemic children by micellar electrokinetic capillary chromatography | |
CN115219614B (en) | High performance liquid chromatography detection method for chlorbenzoguanide hydrochloride in chicken excreta | |
CN104007205A (en) | Method for detecting pharmaceutical preparation for treating xiaoke disease | |
CN110568111B (en) | Method for detecting oligosaccharide in morinda officinalis formula particles | |
López et al. | Determination of cocaine and heroin with their respective metabolites in meconium by gas chromatography‐mass spectrometry | |
CN111735892A (en) | Method for measuring multiple diuretics in animal derived food | |
CN101639467A (en) | Method for determining amount of residual florfenicol in aquatic product by using high-efficiency liquid chromatogram fluorescence method | |
CN113759056B (en) | Characteristic spectrum of Chinese lobelia and preparation thereof and construction method thereof | |
Ascione et al. | Tetracyclines II Separation and determination by column chromatography | |
CN112578035A (en) | High performance liquid chromatography detection method for patulin in pig excreta | |
CN112147239B (en) | Method for detecting nucleoside content in polyporus umbellatus | |
CN107582639A (en) | A kind of vinegar corydalis tuber granule and preparation method thereof | |
CN109932459A (en) | A kind of method of avilamycin in quantitative detection chicken alimentary canal | |
Guo et al. | Simultaneous determination of rivanol and mifepristone in human plasma by a HPLC-UV method with solid-phase extraction | |
Lodge-Ivey et al. | Detection of lysergic acid in ruminal fluid, urine, and in endophyte-infected tall fescue using high-performance liquid chromatography | |
Du et al. | Simultaneous determination of seven active ingredients in rat plasma by UPLC-MS/MS and application in pharmacokinetic studies after oral administration of scutellaria-coptis herb couple | |
CN111965269A (en) | Method for measuring oleanolic acid content and ursolic acid content in patrinia heterophylla by using ultra-high performance liquid chromatography | |
Sorsa | Simultaneous determination of pseudouridine, neopterine and creatinine in urine by ion-pair high-performance liquid chromatography with in-series ultraviolet and fluorescence detection | |
CN113671064B (en) | Detection method for quantitatively analyzing blood concentration of amlexanox in plasma | |
CN114137102B (en) | Method for measuring clenbuterol hydrochloride content in ambroxol oral solution | |
Ezzedeen et al. | Analysis of iodochlorhydroxyquin in biological materials by high-performance liquid chromatography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |